These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 14577021)

  • 41. Cyclosporine A monitoring in children: abbreviated area under curve formulas and C2 level.
    Dello Strologo L; Campagnano P; Federici G; Rizzoni G
    Pediatr Nephrol; 1999 Feb; 13(2):95-7. PubMed ID: 10228991
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Approach to a target value for 2-hours post dose cyclosporine (C2) during the first week post renal transplantation.
    Einollahi B; Taheri S; Lessan-Pezeshki M; Pourfarziani V; Hosseini MS; Nemati E; Ghadiani MH; Abbaszadeh S; Nourbala MH
    Ann Transplant; 2009; 14(1):18-22. PubMed ID: 19289992
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Two-hour cyclosporine concentration determination: an appropriate tool to monitor neoral therapy?
    Oellerich M; Armstrong VW
    Ther Drug Monit; 2002 Feb; 24(1):40-6. PubMed ID: 11805721
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Limited sampling strategies using Bayesian estimation or multilinear regression for cyclosporin AUC(0-12) monitoring in cardiac transplant recipients over the first year post-transplantation.
    Monchaud C; Rousseau A; Leger F; David OJ; Debord J; Dantoine T; Marquet P
    Eur J Clin Pharmacol; 2003 Apr; 58(12):813-20. PubMed ID: 12698308
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A limited sampling strategy for the estimation of Neoral AUCs in pediatric patients.
    Meier-Kriesche HU; Bonilla-Felix MA; Ferris ME; Swinford R; Kahan BD; Brannan P; Portman RJ
    Pediatr Nephrol; 1999 Nov; 13(9):742-7. PubMed ID: 10603112
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Suitable whole blood levels 2 hours after neoral in liver transplant patients: experiences at a single center.
    Kim KH; Lee SG; Lee YJ; Park KM; Hwang S; Ahn CS; Moon DB; Ha TY; Song KW; Kim DS; Jung DH; Kim BS; Moon KM; Lee HJ; Park JI; Ryu JH
    Transplant Proc; 2006 Nov; 38(9):2971-3. PubMed ID: 17112877
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapeutic drug monitoring of cyclosporine.
    Jorga A; Holt DW; Johnston A
    Transplant Proc; 2004 Mar; 36(2 Suppl):396S-403S. PubMed ID: 15041374
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics of mycophenolate mofetil in stable pediatric liver transplant recipients receiving mycophenolate mofetil and cyclosporine.
    Lobritto SJ; Rosenthal P; Bouw R; Leung M; Snell P; Mamelok RD
    Liver Transpl; 2007 Nov; 13(11):1570-5. PubMed ID: 17969194
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cyclosporine exposure and calcineurin phosphatase activity in living-donor liver transplant patients: twice daily vs. once daily dosing.
    Fukudo M; Yano I; Masuda S; Katsura T; Ogura Y; Oike F; Takada Y; Tanaka K; Inui K
    Liver Transpl; 2006 Feb; 12(2):292-300. PubMed ID: 16447186
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Study of the correlation between drug exposure and blood concentration during cyclosporine microemulsion absorption phase in Chinese adult liver transplant recipients].
    Chen G; He Y; Chen YC; Wang HZ; Chen JH; Dong JH
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):328-30. PubMed ID: 15225421
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetics and pharmacodynamics in renal transplant recipients under treatment with cyclosporine and Myfortic.
    Brunet M; Crespo M; Millán O; Serón D; Torregrosa V; Jiménez O; Moreso F; Martorell J; Grinyo JM; Oppenheimer F
    Transplant Proc; 2007 Sep; 39(7):2160-2. PubMed ID: 17889124
    [TBL] [Abstract][Full Text] [Related]  

  • 52. C0 or C2 driven cyclosporine monitoring in long-term pediatric kidney transplant recipients: is there any threat for chronic rejection development?
    Ferraresso M; Ghio L; Edefonti A; Vigano S; Boschiero L; Berardinelli L
    Pediatr Transplant; 2005 Jun; 9(3):328-31. PubMed ID: 15910389
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Target range maximum of cyclosporine blood concentration two hours post dose in stable liver transplant patients.
    Li J; Dahmen U; Beckebaum S; Cicinnati V; Valentin-Gamazo C; Frilling A; Malago M; Broelsch CE
    Eur J Med Res; 2006 Apr; 11(4):139-45. PubMed ID: 16720277
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of pharmacokinetics of Neoral and Sandimmune in stable pediatric liver transplant recipients.
    van Mourik ID; Thomson M; Kelly DA
    Liver Transpl Surg; 1999 Mar; 5(2):107-11. PubMed ID: 10071349
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Longitudinal evaluation of mycophenolic acid pharmacokinetics in pediatric kidney transplant recipients. The role of post-transplant clinical and therapeutic variables.
    Ghio L; Ferraresso M; Zacchello G; Murer L; Ginevri F; Belingheri M; Peruzzi L; Zanon F; Perfumo F; Berardinelli L; Tirelli S; Dello Strologo L; Fontana I; Valente U; Cardillo M; Edefonti A
    Clin Transplant; 2009; 23(2):264-70. PubMed ID: 19191807
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Achieving adequate cyclosporine exposure in liver transplant recipients: a novel strategy for monitoring and dosing using intravenous therapy.
    Lück R; Böger J; Kuse E; Klempnauer J; Nashan B
    Liver Transpl; 2004 May; 10(5):686-91. PubMed ID: 15108262
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of diltiazem on the pharmacokinetics of microemulsion cyclosporine A in renal transplantation.
    Bunnag S; Vareesangthip K; Ong-ajyooth L
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S228-34. PubMed ID: 17044476
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Advantages of C2 monitoring to avoid acute rejection in pediatric heart transplant recipients.
    Schubert S; Abdul-Khaliq H; Lehmkuhl HB; Hübler M; Abd El Rahman MY; Miera O; Ewert P; Weng Y; Wei H; Krüdewagen B; Hetzer R; Berger F
    J Heart Lung Transplant; 2006 Jun; 25(6):619-25. PubMed ID: 16730566
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Population pharmacokinetics and bayesian estimator of cyclosporine in pediatric renal transplant patients.
    Irtan S; Saint-Marcoux F; Rousseau A; Zhang D; Leroy V; Marquet P; Jacqz-Aigrain E
    Ther Drug Monit; 2007 Feb; 29(1):96-102. PubMed ID: 17304156
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparison of the pharmacokinetics of tacrolimus and microemulsified cyclosporin in paediatric renal transplant recipients.
    Renton KW; Crocker JF; McLellan H; Acott PD
    Eur J Clin Pharmacol; 2004 Aug; 60(6):421-6. PubMed ID: 15232662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.